What is the Ind-Swift Laboratories Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 10.78% of the total equity shares of Ind-Swift Laboratories Ltd.

What is the Ind-Swift Laboratories Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 0.20% of the total equity shares of Ind-Swift Laboratories Ltd.

How has the Ind-Swift Laboratories Ltd promoter holding changed?

The promoter holding in Ind-Swift Laboratories Ltd changed from 42.93% to 42.93% during the latest reported period.

How has the Ind-Swift Laboratories Ltd FII holding changed?

The FII holding in Ind-Swift Laboratories Ltd changed from 10.70% to 10.78% during the latest reported period.

How has the Ind-Swift Laboratories Ltd DII holding changed?

The DII holding in Ind-Swift Laboratories Ltd changed from 0.17% to 0.20% during the latest reported period.

Who are the major shareholders of Ind-Swift Laboratories Ltd?

The major shareholders of Ind-Swift Laboratories Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Ind-Swift Laboratories Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Ind-Swift Laboratories Ltd public shareholding?

Public shareholders hold 46.09% of the total equity shares of Ind-Swift Laboratories Ltd as per the latest available data.

Ind-Swift Laboratories Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹327.45

-17.90(-5.18%)

As on 23 Oct 2026 at 15:55

As of 23 Oct 2026 at 15:55, Ind-Swift Laboratories Ltd is trading at ₹327.45. The 52-week range stands at ₹87.15–₹424.75, with a market cap of ₹2.85 thousand crore. At a P/E of 42.68 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.